Artificial intelligence could help to optimise the development of antibody drugs. This leads to active substances with improved properties, also with regard to tolerability in the body.
Many patients use their inhalers and insulin pens wrong. Researchers have developed a system to reduce those numbers for some types of medications.
Researchers have developed a biobattery-powered device capable of both delivering large molecule pharmaceuticals across the skin barrier and extracting interstitial fluid for diagnostic purposes.
A deep learning model that can predict how human genes and medicines will interact has identified at least 10 compounds that may hold promise as treatments for COVID-19.
Scientists have developed a machine learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed.
An AI platform derives an optimal combination of available therapies against SARS-CoV-2 - the optimal drug therapy was a combination of the drugs remdesivir, ritonavir, and lopinavir at specific doses.
Scientists have developed an easy way to make millirobots by coating objects with a glue-like magnetic spray.
Scientists have demonstrated a VR technique which should help in developing drugs against the SARS-CoV-2 virus – and enable researchers to share models and collaborate in new ways.
With the advent of pharmacogenomics, machine learning research is well underway to predict patients' drug response that varies by individual from the algorithms derived from previously collected data on drug responses.
Researchers have found a way to send tiny, soft robots into humans, potentially opening the door for less invasive surgeries and ways to deliver treatments for several conditions.
Researchers have invented a new type of surgical glue that can help join blood vessels and close wounds faster and may also serve as a platform to deliver pain relief drugs.
Engineers have demonstrated that drug levels inside the body can be tracked in real time using a custom smartwatch that analyzes the chemicals found in sweat.
Since mid-2019, the Fraunhofer IBMT has been developing an analysis platform as an alternative to animal experiments in drug development.
Researchers used a skin cream infused with microscopic particles, named STAR particles, for therapy of Skin diseases